Market Vectors Biotech ETF (BBH)

  • Loading...
#8

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 16 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Good
Tracking Error Good
Bid/Ask Ratio Good
Holdings Diversity Good

Fund Description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Fund Snapshot Updated 04.23.2014

Previous Close $88.33 Expense Ratio 0.35%
YTD Return 0.61% Avg. 30-Day Volume 307,055
1-Year Return 27.5% Market Cap Loading...
Bid $87.98 Shares Outstanding 5,646,000
Ask $88.04 Dividends $0.00
Top 10 Holdings
Gilead Sciences Inc (GILD) 12.94%
Amgen Inc (AMGN) 10.89%
Biogen Idec Inc (BIIB) 9.23%
Celgene Corp (CELG) 8.77%
Alkermes Plc (ALKS) 5.15%
Regeneron Pharmaceuticals (REGN) 5.11%
Alexion Pharmaceuticals Inc (ALXN) 4.90%
Illumina Inc (ILMN) 4.70%
Vertex Pharmaceuticals Inc (VRTX) 4.32%
Biomarin Pharmaceutical Inc (BMRN) 3.68%
% of Total Holdings 69.70%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds